NNNN
Anbio Biotechnology
6.30$
-0.2%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | +431.7% | -71.5% | +21.9% | +5.6% | |
| – | +482.1% | -69.5% | -31.4% | -52.0% | |
| – | +394.3% | -73.2% | +75.1% | +28.2% | |
| – | – | -32.7% | +237.2% | -55.7% | |
| – | +2,418.4% | -41.6% | +171.6% | -54.2% | |
| – | +2,650.7% | -40.9% | +177.9% | -54.4% | |
| – | +315.2% | -80.8% | +1.8% | +189.1% | |
| – | – | -100.0% | – | – | |
| – | +294.8% | -77.5% | +5.3% | +169.9% | |
| – | +294.8% | -77.5% | +5.3% | +169.9% | |
| – | +295.4% | -77.4% | -12.0% | +189.1% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.